(Q30834887)

27 June 2017

title

The pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures (English)

1 reference

27 June 2017

1 reference

chronic fatigue syndrome

1 reference

P. Manu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1338059

15 September 2022

T. J. Lane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1338059

15 September 2022

D. A. Matthews

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1338059

15 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1338059

15 September 2022

publication date

1 January 1992

1 reference

International Journal of Psychiatry in Medicine

27 June 2017

published in

1 reference

27 June 2017

volume

22

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

397-408

1 reference

Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Postviral fatigue syndrome: time for a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Chronic fatigue syndrome: clinical condition associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

The psychiatric status of patients with the chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Attributions and self-esteem in depression and chronic fatigue syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Coxsackie B viruses and myalgic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

WHAT IS MYALGIC ENCEPHALOMYELITIS?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F20AP-D23D-YMF5-ELTL

10.2190/20AP-D23D-YMF5-ELTL

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference